Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toward cocaine esterase therapeutics.

Claude J Rogers1, Jenny M Mee, Gunnar F Kaufmann

  • 1The Skaggs Institute for Chemical Biology and Departments of Chemistry and Immunology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, USA.

Journal of the American Chemical Society
|July 14, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Redefining Drug Immune Recognition: A Radically Reconfigured Molecular Architecture Enables Broad Fentanyl-Class Protection.

Journal of medicinal chemistry·2026
Same author

Fentanyl-Rewired: A 2‑Azaspiro[3.3]heptane Core Preserves μ‑Opioid Function.

ACS medicinal chemistry letters·2026
Same author

Bifunctional Behavior of Conformationally Constrained Methamphetamine Analogs: Unexpected Heteroclitic Immune Response and Antagonist Effects Altering Methamphetamine and Fentanyl Pharmacology.

Journal of medicinal chemistry·2025
Same author

Solid-phase synthesis of a pyrrole library and identification of bioactive compounds.

Bioorganic & medicinal chemistry letters·2025
Same author

Multicentered Biospecimen Analyses after 4 Gy Sublethal Total Body Irradiation in Rhesus Macaques.

Radiation research·2025
Same author

Bifunctional Inhibition of Botulinum Neurotoxin A Protease: Unexpected Active Site Inhibition Enhances Covalent Targeting of an Allosteric Site.

Journal of medicinal chemistry·2025

Researchers developed novel cocaine esterases using phage display technology. These enzymes show promise for cocaine abuse pharmacotherapy due to their effective kinetic properties.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Drug Abuse Research

Background:

  • Cocaine is a highly addictive substance with significant public health implications.
  • Current pharmacotherapies for cocaine abuse are limited, necessitating novel treatment strategies.

Purpose of the Study:

  • To develop and characterize novel cocaine esterases for potential use in treating cocaine abuse.
  • To assess the enzymatic activity and kinetic parameters of engineered cocaine esterases.

Main Methods:

  • Utilized phage display technology for the selection and engineering of cocaine esterases.
  • Characterized the kinetic parameters (kcat/Km) of the developed enzymes.

Main Results:

  • Successfully developed phage-displayed cocaine esterases.

Related Experiment Videos

  • Achieved pharmacologically relevant kinetic parameters (kcat/Km approximately 10^4 M^-1 s^-1).

    • Conclusions:

    • Phage-displayed cocaine esterases represent a promising avenue for cocaine abuse pharmacotherapy.
    • The characterized enzymes possess suitable kinetic properties for potential clinical application.